January 30, 2018 / 3:50 PM / 6 months ago

BRIEF-U.S. FDA Requests Labeling And Packaging Changes For OTC Loperamide

Jan 30 (Reuters) - U.S. Food and Drug Administration Commissioner Scott Gottlieb:

* STATEMENT FROM FDA COMMISSIONER SCOTT GOTTLIEB - FDA IS REQUESTING THAT SPONSORS OF OTC LOPERAMIDE CHANGE THE WAY THEY LABEL AND PACKAGE THESE DRUGS

* FDA’S GOTTLIEB - REQUESTING OTC MANUFACTURERS THAT PACKAGES CONTAIN LIMITED AMOUNT OF LOPERAMIDE APPROPRIATE FOR USE FOR SHORT-TERM DIARRHEA ACCORDING TO PRODUCT LABEL Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below